Dissident AIDS Database

NIAID paper : HIV causes AIDSGeneralSurvival with AZT/PIsPlacebo effect
False positive viral loads : what are we really measuring
 Irwin Matt
  Because viral loads are commonly thought to represent the number of viruses per milliliter of blood, it can be terrifying to hear that one's viral load is in the thousands, hundreds of thousands, or even in the millions. Receiving good news, such as being informed of a dramatically lowered viral load because of HAART can have a direct effect on a person's physiology, even if the RNA being measured is not coming from HIV and reduce the emotional and psychological problems such as anxiety and depression which can be severe in people diagnosed HIV-positive. Enhancing psychological and emotional well-being may promote various health behaviors such as exercise, good nutrition, improved medical care, and self-care...
Effects of suggestion and conditioning on the action of chemical agents in human subjects: the pharmacology of placebos.
 Wolf S
  The author of the study gave a group of women a toxic substance called syrup of ipecac that causes nausea and vomiting. He lied to the women, however, telling them it was actually a drug that would cure nausea and vomiting. The women in the study were already suffering from chronic nausea and vomiting of pregnancy, and so they gladly took the syrup of ipecac. In most cases their symptoms ceased entirely. Objective evidence of their improvement was also measured by Dr. Wolf, who had the patients swallow small tubes to measure the amount of muscle contractions in the stomach, contractions that occur with the heaving which occure when one vomits. After taking the toxin, the contractions subsided.
  Journal of Clinical Investigation; 1950; 29; 100-109.1950
 Irwin Matt
  Participants and researchers in placebo-controlled studies are naturally curious as to whom is getting the real drug and who is not. Especially for the participants, it is likely to be a question that is repeatedly on their minds while they take their daily regimen of pills. This has been supported by research studies designed to look at this question which have found that patients and physicians involved in "double blind" studies can correctly guess who is getting placebo and who is not about 70% to 80% of the time (Greenberg R & Fisher S (1997). From placebo to panacaea. Wiley, New York). There are several reasonable explanations for this finding. In the case of HIV, one is that the viral load is often reduced more by active medications. Another is that the groups receiving the active medications also have significantly more side effects... This opens up a Pandora's box of questions regarding the effectiveness of most drug treatments and may explain why studies like these have not been followed up. If the placebo effect can be so powerful it becomes a serious threat to people who have invested their time and energy into drug treatments.